Unknown

Dataset Information

0

A palindromic CpG-containing phosphodiester oligodeoxynucleotide as a mucosal adjuvant stimulates plasmacytoid dendritic cell-mediated T(H)1 immunity.


ABSTRACT:

Background

CpG oligodeoxynucleotides (ODNs), resembling bacterial DNA, are currently tested in clinical trials as vaccine adjuvants. They have the nuclease-resistant phosphorothioate bond; the immune responses elicited differ according to the CpG ODN sequence and vaccination method. To develop a CpG ODN that can induce plasmacytoid dendritic cell (pDC)-mediated T(H)1 immunity through the mucosa, we constructed phosphodiester G9.1 comprising one palindromic CpG motif with unique polyguanosine-runs that allows degradation similar to naturally occurring bacterial DNA.

Methods

T(H)1 and T(H)2 immunity activation was evaluated by cytokine production pattern and T-bet/GATA-3 ratio in human peripheral blood mononuclear cells and mouse bone marrow cells. Adjuvanticity was evaluated in mice administered G9.1 with diphtheria toxoid (DT) through nasal vaccination.

Results

G9.1 exhibited stronger IFN-?-inducing activity than A-class CpG ODN2216 and increased T-bet/GATA-3 ratio by enhancing T-bet expression. Nasally administered G9.1 plus DT induced DT-specific mucosal IgA and serum IgG, but not IgE, responses with antitoxin activity in C57BL/6 and BALB/c mice, possibly due to IFN/BAFF production. Induction of T(H)1, but not T(H)2-type Abs depended completely on pDCs, the first in vivo demonstration by CpG ODNs.

Conclusions

G9.1 is a promising mucosal adjuvant for induction of pDC-mediated T(H)1 immunity.

SUBMITTER: Maeyama J 

PROVIDER: S-EPMC3933336 | BioStudies | 2014-01-01

REPOSITORIES: biostudies

Similar Datasets

2012-01-01 | S-EPMC3356174 | BioStudies
2016-01-01 | S-EPMC4997267 | BioStudies
2012-01-01 | S-EPMC3405294 | BioStudies
1000-01-01 | S-EPMC1976374 | BioStudies
2014-01-01 | S-EPMC4060301 | BioStudies
2012-07-01 | GSE30849 | GEO
1000-01-01 | S-EPMC5074278 | BioStudies
1000-01-01 | S-EPMC6234694 | BioStudies
2013-01-01 | S-EPMC3870712 | BioStudies
2020-01-01 | S-EPMC7015978 | BioStudies